SEC Form 4 · accession 0001405626-18-000002
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denis Corin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 5, 2017
Accepted (ET)
Jun 6, 2018 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionsF1 | $4.00 | Jun 5, 2017 | A | 12,500 | A | Jun 5, 2018 | Jun 5, 2022 | Common Stock | 12,500 | 600,000 | D |
| Incentive Stock OptionsF2 | $4.00 | Jun 5, 2017 | P | 25,000 | A | Jun 5, 2018 | Jun 5, 2022 | Common Stock | 25,000 | 625,000 | D |
| Incentive Stock OptionsF1,F3 | $3.35 | May 31, 2018 | P | 50,000 | A | — | May 31, 2023 | Common Stock | 50,000 | 675,000 | D |
| Incentive Stock OptionsF2,F4 | $3.35 | May 31, 2018 | P | 100,000 | A | — | May 31, 2023 | Common Stock | 100,000 | 775,000 | D |
Explanation of responses
- F1Issued for director services.
- F2Issued for officer services.
- F3These options vest in four equal installments of 12,500 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on May 31, 2018.
- F4These options vest in four equal installments of 25,000 each, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. The first installment vested on May 31, 2018.